Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q4 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −1,500,000−100.0% | Sold out | Holders |
| Q2 2024 | 1,500,000 | $2.85M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,500,000 | $4.26M | 0.2% | +1,500,000 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −2,084,000−100.0% | Sold out | Holders |
| Q3 2023 | 2,084,000 | $38.2M | 2.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,084,000 | $45.0M | 2.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,084,000 | $61.1M | 3.0% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,084,000 | $77.0M | 4.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,084,000 | $58.7M | 3.3% | −116,000−5.3% | Reduced | Holders |
| Q2 2022 | 2,200,000 | $42.4M | 2.7% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,200,000 | $28.3M | 1.5% | +2,200,000 | New | Holders |